Unlocking Cancer Priming Therapies (& Lab Tour) - Transon Nguyen of Eigen Therapeutics

Transon Nguyen is the CEO and Co-Founder of Eigen Therapeutics, a biotech startup leveraging AI and lab automation to develop priming therapies that make cancer easier to find and eliminate. Hosted by Nabil Laoudji. My guest co-host is Jimmy Sastra! This episode is sponsored by Monomer Bio. See below for episode links, chapters, and how to connect with us.Thanks for watching 🙏🤙Episode Links: Eigen Therapeutics Transon Nguyen's LinkedIn Monomer Bio Jimmy Sastra's LinkedIn Radioligand Therapy Antibody–Drug Conjugates (ADCs) Laboratory Information Management System (LIMS) Chapters: (00:00) - Teaser (00:36) - Introducing My Guest Co-Host: Jimmy Sastra of Monomer Bio (11:24) - Introducing Transon Nguyen, CEO of Eigen Therapeutics (12:54) - Transon's Path Into Biomedical Engineering (15:45) - Science In Industry vs Academia: Importance of Culture (18:27) - Co-Founding Eigen Tx: A Confluence of Factors (24:27) - How to Find New Ideas (25:15) - Cost of ADCs and Radioligand Therapies (27:00) - Testing The Effectiveness of Priming Therapies (31:23) - How Patients Take Priming Therapies (33:19) - Importance of Empathy In Multidisciplinary Teams (37:54) - Lab Tour: Intro, Flexible Design (39:33) - Different "Homes" / Areas of The Lab (43:32) - Custom Built LIMS (48:54) - Robot Test Suite Demo (51:41) - A Look At Custom-Built LIMS (55:56) - Favorite Instruments (57:44) - Business of BioTech: Making The Numbers Work (59:09) - Don't Over-Automate (01:01:13) - Keeping The Lab Clean (01:03:01) - Moving Beyond Just Solving Problems (01:05:05) - Reframing Personal Identity and Seeing the Whole System (01:08:31) - Relevance of AI Foundation Models, Virtual Cells to Eigen's Mission (01:12:50) - Contact Transon to Learn More About Priming Therapies Connect With Us: Our Newsletter Twitter Bluesky LinkedIn Feedback or questionsPlatforms: YouTube Apple Podcasts Spotify Podcasts

There are no comments yet.

Please log in to write the first comment.